All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drtaniaelliott on TikTok · 32s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @drtaniaelliott's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Don't touch this.
  2. 0:02I'm Dr. Tonya Elliott, Board Certified Internal Medicine Specialist and Allurgist.
  3. 0:06Most receipts use thermal paper containing bisphenols or BPA and they are easily absorbed
  4. 0:12into the bloodstream.
  5. 0:13These chemicals are toxic and a study showed 80% of receipts contain toxic BPA.
  6. 0:19What are these chemicals?
  7. 0:20Duryabani?
  8. 0:21They are the famous hormone disruptors which give you the impact fertility, hormone balance,
  9. 0:26and increased risk of certain cancers.
  10. 0:28Now I don't want to be an alarmist here, but just opt for an email receipt.

@drtaniaelliott's BPA receipt claims, fact-checked

drtaniaelliott

TikTok creator

6.3M viewsWatch on TikTok

Quick answer

Bisphenol A is a well-characterized endocrine disruptor with confirmed dermal absorption from thermal receipt paper, though real-world exposure from casual handling is low for most people. For patients actively managing hormone levels, such as those on testosterone replacement therapy, minimizing cumulative environmental estrogen mimics is a reasonable clinical consideration, though receipts alone are unlikely to produce clinically significant hormone disruption. Regulatory bodies including EFSA significantly lowered their tolerable daily intake thresholds for BPA in 2023, reflecting evolving concern about chronic low-dose exposure rather than acute toxicity.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drtaniaelliott's BPA receipt claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@drtaniaelliott's BPA receipt claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@drtaniaelliott's BPA receipt claims, fact-checked" from drtaniaelliott. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Bisphenol A is a well-characterized endocrine disruptor with confirmed dermal absorption from thermal receipt paper, though real-world exposure from casual handling is low for most people.

The reason this review is not generic is the source wording and the canonical claim label "trt don t touch this most receipts use thermal paper cont." In this clip, the useful excerpt is: "Don't touch this." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Dermal absorption of BPA from receipts spikes when alcohol-based hand sanitizer is used first, according to Hormann et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Bisphenol A is a well-characterized endocrine disruptor with confirmed dermal absorption from thermal receipt paper, though real-world exposure from casual handling is low for most people.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Bisphenol A is a well-characterized endocrine disruptor with confirmed dermal absorption from thermal receipt paper, though real-world exposure from casual handling is low for most people. For patients actively managing hormone levels, such as those on testosterone replacement therapy, minimizing cumulative environmental estrogen mimics is a reasonable clinical consideration, though receipts alone are unlikely to produce clinically significant hormone disruption. Regulatory bodies including EFSA significantly lowered their tolerable daily intake thresholds for BPA in 2023, reflecting evolving concern about chronic low-dose exposure rather than acute toxicity.
  • 94% of thermal receipt paper samples in one multi-country study (Liao and Kannan, 2012) contained BPA, making the core claim about receipt contamination well-supported.
  • Dermal absorption of BPA from receipts spikes when alcohol-based hand sanitizer is used first, according to Hormann et al. (2014, PLOS ONE). Brief contact with dry hands produces lower but still measurable absorption.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • 94% of thermal receipt paper samples in one multi-country study (Liao and Kannan, 2012) contained BPA, making the core claim about receipt contamination well-supported.
  • Dermal absorption of BPA from receipts spikes when alcohol-based hand sanitizer is used first, according to Hormann et al. (2014, PLOS ONE). Brief contact with dry hands produces lower but still measurable absorption.
  • BPS and BPF, common BPA replacements marketed as safer, show similar endocrine-disrupting activity to BPA according to a 2015 review by Rochester and Bolden in Environmental Health Perspectives.
  • Cashiers and others with occupational receipt exposure show consistently elevated urinary BPA levels compared to the general population (Gig et al., 2015, Environment International), making this a more pressing concern for high-frequency handlers.
  • EFSA reduced its tolerable daily intake for BPA by a factor of approximately 20,000 in 2023, reflecting increased regulatory concern about chronic low-dose exposure to bisphenols.
  • For patients on hormone replacement therapy or testosterone therapy, reducing background exposure to estrogenic chemicals is a reasonable low-effort habit, though receipts alone are unlikely to cause clinically significant hormone disruption.
  • Requesting digital receipts is a simple, no-cost intervention that eliminates this specific exposure route entirely.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drtaniaelliott actually say?

Dr. Elliott warned viewers to stop touching paper receipts, stating that "most receipts use thermal paper containing bisphenols or BPA" and that these chemicals are "easily absorbed into the bloodstream." She cited a study claiming "80% of receipts contain toxic BPA" and linked bisphenol exposure to hormone disruption, fertility problems, and increased cancer risk. Her takeaway was simple: opt for the email receipt instead.

She was careful to add "I don't want to be an alarmist here," which is worth noting. The framing stayed practical rather than catastrophizing. But several of her specific claims deserve scrutiny, because the science is more complicated than a 60-second TikTok can carry.

Does the science back this up?

Mostly, yes, with some important caveats around dose and actual risk. The thermal paper claim is well-documented. A 2012 study by Liao and Kannan published in Environmental Science and Technology found BPA in 94% of thermal receipt paper samples tested across multiple countries, and dermal absorption from handling receipts has been confirmed in human studies.

The skin absorption piece is real but often overstated. A 2014 study by Hormann et al. in PLOS ONE showed that handling receipts after using hand sanitizer significantly increased BPA absorption through the skin, because alcohol-based products strip the skin's natural barrier. Without that compounding factor, absorption from casual handling is measurable but low.

On hormone disruption: BPA's estrogenic activity is established in animal and in vitro research. The human epidemiological evidence linking BPA to fertility outcomes and cancer risk is associational, not conclusively causal. That distinction matters. The National Toxicology Program and EFSA have both revisited their safe exposure thresholds in recent years, with EFSA dramatically lowering its tolerable daily intake in 2023, which signals growing regulatory concern.

What did they get wrong (or right)?

The "80% of receipts contain toxic BPA" figure is a reasonable approximation from the literature, though the exact percentage varies by study and region. Calling that number settled fact without a citation is a minor overstep.

What's more misleading is the phrase "easily absorbed into the bloodstream." Dermal absorption of BPA from receipt handling does occur, but the word "easily" implies a level of efficiency that the data does not fully support for normal, brief contact. The Hormann 2014 data shows absorption spikes under specific conditions, like wet or compromised skin, not from a quick grab at the grocery checkout.

She also lumped bisphenols together as uniformly toxic. Many manufacturers have shifted from BPA to BPS or BPF, which are marketed as safer alternatives. The problem: BPS and BPF appear to have similar endocrine-disrupting properties. A 2015 review by Rochester and Bolden in Environmental Health Perspectives found BPS and BPF are not meaningfully safer than BPA. So Elliott's broader warning about bisphenols as a class holds up better than a BPA-only framing would.

The recommendation to choose email receipts is genuinely reasonable and carries no real downside. Credit where it's due.

What should you actually know?

If you handle receipts occasionally at a checkout counter, your exposure is low and probably not a clinically meaningful concern on its own. Where this gets more relevant is for people with occupational exposure, like cashiers handling receipts for hours every day. Studies on that population, including work by Gig and colleagues published in Environment International (2015), show consistently elevated urinary BPA levels compared to the general population.

For anyone on hormone therapy, including testosterone replacement therapy, the endocrine-disrupting potential of bisphenols is worth taking seriously as a background exposure. BPA competes with estrogen at receptor sites, and that kind of interference is not trivial when you are actively managing hormone levels. It does not mean receipts will tank your testosterone. It means reducing unnecessary chemical exposures is a reasonable low-effort habit.

The practical steps are simple. Wash hands after handling receipts, avoid skin contact if you use hand sanitizer frequently, and request digital receipts when available. These are reasonable, proportionate responses, not panic.

Bottom line

Dr. Elliott got the core science directionally right. Thermal paper does contain bisphenols, those chemicals are absorbed through skin, and they do interfere with hormone signaling. Her recommendation is sensible. The gaps are in the precision of the claims, particularly around how readily absorption happens under normal conditions and whether the cancer and fertility risks she cited apply at the exposure levels most people actually encounter from receipts. This video earns a "mostly accurate" overall, with the caveat that the framing makes routine receipt handling sound more dangerous than the current evidence supports for the average person.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

drtaniaelliott · TikTok creator

6.3M views on this video

Don’t touch this! ✋🏼 Most receipts use thermal paper containing bisphenols, or BPA, and they are easily absorbed into the bloodstream. ☠️These chemicals are toxic, and a study showed 80% of recei

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about 94% of thermal receipt paper samples in one multi-country study?

94% of thermal receipt paper samples in one multi-country study (Liao and Kannan, 2012) contained BPA, making the core claim about receipt contamination well-supported.

What does the video say about dermal absorption of bpa from receipts spikes?

Dermal absorption of BPA from receipts spikes when alcohol-based hand sanitizer is used first, according to Hormann et al. (2014, PLOS ONE). Brief contact with dry hands produces lower but still measurable absorption.

What does the video say about bps?

BPS and BPF, common BPA replacements marketed as safer, show similar endocrine-disrupting activity to BPA according to a 2015 review by Rochester and Bolden in Environmental Health Perspectives.

What does the video say about cashiers?

Cashiers and others with occupational receipt exposure show consistently elevated urinary BPA levels compared to the general population (Gig et al., 2015, Environment International), making this a more pressing concern for high-frequency handlers.

What does the video say about efsa reduced its tolerable daily intake for bpa by a?

EFSA reduced its tolerable daily intake for BPA by a factor of approximately 20,000 in 2023, reflecting increased regulatory concern about chronic low-dose exposure to bisphenols.

What does the video say about for patients on hormone replacement therapy?

For patients on hormone replacement therapy or testosterone therapy, reducing background exposure to estrogenic chemicals is a reasonable low-effort habit, though receipts alone are unlikely to cause clinically significant hormone disruption.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by drtaniaelliott, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.